Costs and Outcomes of Prolonged Cytomegalovirus Prophylaxis to Cover the Enhanced Immunosuppression Phase Following Lung Transplantation
- 1 November 1999
- Vol. 116 (5) , 1265-1272
- https://doi.org/10.1378/chest.116.5.1265
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- PROPHYLACTIC GANCICLOVIR TREATMENT REDUCES FUNGAL AS WELL AS CYTOMEGALOVIRUS INFECTIONS AFTER HEART TRANSPLANTATION1,2Transplantation, 1995
- A comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation.American Journal of Respiratory and Critical Care Medicine, 1994
- Results of single and bilateral lung transplantation in 131 consecutive recipientsThe Journal of Thoracic and Cardiovascular Surgery, 1994
- Cytomegalovirus Infection and Pneumonitis: Impact after Isolated Lung TransplantationAmerican Review of Respiratory Disease, 1993
- Ganciclovir Prophylaxis for Cytomegalovirus Infections in Pulmonary Allograft RecipientsAmerican Review of Respiratory Disease, 1992
- Pulmonary transplantationThe Journal of Thoracic and Cardiovascular Surgery, 1992
- A Randomized, Controlled Trial of Prophylactic Ganciclovir for Cytomegalovirus Pulmonary Infection in Recipients of Allogeneic Bone Marrow TransplantsNew England Journal of Medicine, 1991
- CYTOMEGALOVIRUS SEROLOGIC STATUS AND POSTOPERATIVE INFECTION CORRELATED WITH RISK OF DEVELOPING CHRONIC REJECTION AFTER PULMONARY TRANSPLANTATIONTransplantation, 1991
- Impact of Cytomegalovirus Infection on Organ Transplant RecipientsClinical Infectious Diseases, 1990
- Virus infections after transplantation in manArchiv für die gesamte Virusforschung, 1977